We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » NIH’s ACTIV Partnership Picks Six COVID-19 Treatment Candidates for Trials
NIH’s ACTIV Partnership Picks Six COVID-19 Treatment Candidates for Trials
The National Institutes of Health (NIH)’s public-private partnership to work on COVID-19 has decided on six existing treatments to evaluate in trials later this month, and said it looks to have vaccine candidates ready for trials by the start of July.